AHIMA September 16, 2021
Chantal Worzala, PhD

In his July 9 Executive Order on promoting competition, President Biden directed the Department of Health and Human Services to “support existing price transparency initiatives for hospitals, other providers, and insurers along with any new price transparency initiatives or changes made necessary by the No Surprises Act or any other statutes.” This statement signaled that the new Administration would build on policies adopted by the Trump Administration to promote more public information about not only the cost-sharing amounts consumers face, but also the prices payers, providers, and drug companies negotiate.

Proponents of greater transparency argue these requirements will promote consumer choice, protect consumers from unexpected costs, and lead to greater competition and lower prices. Critics, however, say these requirements are burdensome and may not...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Govt Agencies, Health System / Hospital, Healthcare System, HHS, Pricing / Spending, Provider
“Complexity is Profitable” in U.S. Healthcare – How to Save a Quarter-Trillion Dollars
Pricing Transparency
NIH study suggests people with rare diseases face significantly higher health care costs
Health Care Costs for Patients With Rare Disease Greater Than Previously Estimated
Expanding health care access and equity through telehealth